It's time to replace the personality disorders with the interpersonal disorders.
Aidan G C Wright, Whitney R Ringwald, Christopher J Hopwood...
https://pubmed.ncbi.nlm.nih.gov/36595407/Actively Recruiting
Led by AddiPsy · Updated on 2025-04-09
154
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are evaluating a new approach called GPM-extended, a dimensional adaptation of Good Psychiatric Management, for treating adults with borderline personality disorder BPD. This trial compares the effectiveness of GPM-extended with classic Good Psychiatric Management in reducing BPD symptoms and improving related areas such as personality functioning, emotional regulation, and social functioning over one year. The study aims to advance personalized, evidence-based treatments for personality disorders by integrating specific triggers from narcissistic and obsessive-compulsive personality disorders into the treatment for BPD. Participants receive outpatient psychiatric care for one year in one of two groups either GPM-extended or classic GPM. Both treatments include weekly one-hour individual therapy and psychiatric case management every three weeks. The GPM-extended group focuses therapy on key personality dilemmas like fear of abandonment, self-esteem issues, and control dependency, with tailored group programs including psychoeducation and skills training. The classic GPM group applies a standardized approach focusing on interpersonal sensitivity, with similar group components. During the study, patients are assessed at the start, 4 months, 8 months, and one year using clinician and self-report measures of BPD symptoms and other psychological factors. Researchers monitor changes in symptom severity, personality functioning, social disability, suicidal behaviors, emotional regulation, and therapeutic alliance, among others. The study tracks treatment response and dropout rates while providing comprehensive evaluation throughout the year-long outpatient care.
CONDITIONS
Evaluation of a Dimensional Adaptation of Good Psychiatric Management (GPM-extended) for the Treatment of Borderline Personality Disorder
M
Martin Blay, M.D., M.Sc
F
Frédéric Mazenod
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
AddiPsy
Lead Sponsor
Clinique Caradoc
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 year
Participants receive one year of outpatient treatment for borderline personality disorder. This includes weekly 1-hour individual therapy tailored either to dominant personality dilemmas (GPM-extended) or interpersonal hypersensitivity (Classic GPM), psychiatric case management every 3 weeks, and group programs including psychoeducation and, if needed, skills training for emotion dysregulation.
Weekly individual therapy visits and case management every 3 weeks; group sessions as scheduled
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aidan G C Wright, Whitney R Ringwald, Christopher J Hopwood...
https://pubmed.ncbi.nlm.nih.gov/36595407/Christopher J Hopwood, Roman Kotov, Robert F Krueger...
https://pubmed.ncbi.nlm.nih.gov/29226598/Martin Blay, Inès Benmakhlouf, Marion Zenou...
https://pubmed.ncbi.nlm.nih.gov/41675670/Shelley F McMain, Tim Guimond, David L Streiner...
https://pubmed.ncbi.nlm.nih.gov/22581157/Maria Elena Ridolfi, Roberta Rossi, Giorgia Occhialini...
https://pubmed.ncbi.nlm.nih.gov/31917907/Bo Bach, Ueli Kramer, Stephan Doering...
https://pubmed.ncbi.nlm.nih.gov/35361271/Martin Blay, Ines Benmakhlouf, Miguel Duarte...
https://pubmed.ncbi.nlm.nih.gov/37564248/Shelley F McMain, Paul S Links, William H Gnam...
https://pubmed.ncbi.nlm.nih.gov/19755574/John G Gunderson, Sabine C Herpertz, Andrew E Skodol...
https://pubmed.ncbi.nlm.nih.gov/29795363/Aidan G C Wright, Christopher J Hopwood, Andrew E Skodol...
https://pubmed.ncbi.nlm.nih.gov/27819472/AddiPsy
Lead Sponsor
Clinique Caradoc
Collaborating Sponsor